eudragit rs has been researched along with Inflammation in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Atefi Khah, M; Dehghani, MA; Khorsandi, L; Mahdavinia, M; Moghimipour, E; Shakiba Maram, N | 1 |
Katara, R; Majumdar, DK; Sachdeva, S | 1 |
Adedokun, MO; Attama, AA; Kenechukwu, FC; Momoh, MA; Odo, CE | 1 |
Das, MK; Deka, A; Kalita, B; Sarma, M | 1 |
Katara, R; Majumdar, DK | 1 |
Ertan, G; Güneri, T; Ozcan, I; Ozgüney, I | 1 |
6 other study(ies) available for eudragit rs and Inflammation
Article | Year |
---|---|
Protective effect of gallic acid and gallic acid-loaded Eudragit-RS 100 nanoparticles on cisplatin-induced mitochondrial dysfunction and inflammation in rat kidney.
Topics: Acrylic Resins; Administration, Oral; Animals; Cisplatin; Dose-Response Relationship, Drug; Gallic Acid; Inflammation; Injections, Intraperitoneal; Kidney Diseases; Male; Mitochondria; Nanoparticles; Oxidative Stress; Protective Agents; Rats; Rats, Wistar | 2020 |
Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Chemistry, Pharmaceutical; Crystallization; Diclofenac; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Eye Diseases; Inflammation; Nanoparticles; Neutrophils; Particle Size; Rabbits | 2019 |
Pharmacodynamics of diclofenac from novel Eudragit entrapped microspheres.
Topics: Acrylic Resins; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemistry, Pharmaceutical; Diclofenac; Disease Models, Animal; Drug Carriers; Female; Hydrogen-Ion Concentration; Inflammation; Male; Microspheres; Particle Size; Rats, Wistar; Solubility; Technology, Pharmaceutical | 2014 |
Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch.
Topics: Acrylic Resins; Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Carrageenan; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Delivery Systems; Edema; Inflammation; Male; Permeability; Phospholipids; Polyethylene Glycols; Polymers; Rabbits; Rats; Rats, Wistar; Resveratrol; Skin; Skin Absorption; Stilbenes; Transdermal Patch | 2017 |
Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Arachidonic Acid; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cornea; Diclofenac; Drug Delivery Systems; Drug Stability; Eye; Goats; Inflammation; Nanoparticles; Particle Size; Permeability; Polymers; Rabbits; Solutions; Spectroscopy, Fourier Transform Infrared; Static Electricity; Surface Properties; Suspensions; X-Ray Diffraction | 2013 |
The preparation and evaluation of sustained release suppositories containing ketoprofen and Eudragit RL 100 by using factorial design.
Topics: Acrylic Resins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Carrageenan; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Delayed-Action Preparations; Diffusion; Drug Compounding; Excipients; Inflammation; Ketoprofen; Kinetics; Male; Octanols; Rats; Solubility; Suppositories; Water | 2007 |